CN1383847A - Chinese medicine composition for treating sequelae for cerebral infraction - Google Patents

Chinese medicine composition for treating sequelae for cerebral infraction Download PDF

Info

Publication number
CN1383847A
CN1383847A CN 01117635 CN01117635A CN1383847A CN 1383847 A CN1383847 A CN 1383847A CN 01117635 CN01117635 CN 01117635 CN 01117635 A CN01117635 A CN 01117635A CN 1383847 A CN1383847 A CN 1383847A
Authority
CN
China
Prior art keywords
radix
medicine composition
chinese medicine
blood
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 01117635
Other languages
Chinese (zh)
Inventor
孙希平
王平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 01117635 priority Critical patent/CN1383847A/en
Publication of CN1383847A publication Critical patent/CN1383847A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to one kind of Chinese medicine composition for treating protrusion of lumber interverterbal disc. It has special recipe developed based on the treating method of invigorating liver and kidney, benefiting vital energy and blood and stopping Bi pain and is prepared into capsule filled with fine medicine powder. The present invention is an organic combination of Chinese medical theory and practice and the medicine has reliable curative effect and no toxic side effect.

Description

The Chinese medicine composition of treatment cerebral infarction sequela
The present invention relates to a kind of Chinese medicine composition for the treatment of cerebral infarction.During modern times were clinical, the brain jam day for human beings was cumulative many, and modern medicine treatment primary disease adopts blood vessel dilating more, microcirculation improvement, and nourishing brain cell, dehydrations etc. have definite curative effect to patients during acute stage, but relatively poor to curative effects such as sequela such as hemiplegias.Motherland's therapeutic treatment cerebral infarction sequela, according to old weakness of QI, in conjunction with the objective knowledge of modern medicine to primary disease, as there is high blood viscosity etc. in the theory of blood stasis due to qi deficiency, thinks that " blood stasis due to qi deficiency " is the main pathogenesis of sequela." benefiting QI for activating blood circulation, blood nourishing acupuncture-stimulating " is the main rule of treatment of primary disease, and said composition is exactly the specific prescription for certain illness of developing on this basis.
The present invention is achieved in that the composition percentage by weight of invention medicine is: the Radix Astragali 21%, Radix Paeoniae Rubra 9%, Radix Angelicae Sinensis 11%, Pheretima 6.5%, Rhizoma Chuanxiong 13%, uncommon Herba Siegesbeckiae 11%, Semen Persicae 11%, Flos Carthami 11%, Radix Glycyrrhizae 6%, Hirudo 6.5%.
Preparation: grind to the powder altogether, make capsule, every heavily about 0.45g of pastille with capsule filler.
Cure mainly: the benefiting QI for activating blood circulation collateral dredging cures mainly apoplexy sequela---hemiplegia.
Usage: each 5, every day 3 times, 1 month is a course of treatment.
Points for attention: regulate feelings will during the medication, strengthen rehabilitation training.
Medicine of the present invention at the dialectical genus blood stasis due to qi deficiency of cerebral infarction sequela patient.Motherland's medical science thinks that the cerebral infarction patient is old for many years, the deficiency of vital energy, and the capable then blood of gas is capable, and the deficiency of vital energy is blood stasis then, and blood stasis must stop, and passages through which vital energy circulates is obstructed, so hemiplegia occurs.The benefiting QI for activating blood circulation collateral dredging is answered in treatment.Radix Astragali master is a principal agent with big invigorating middle warmer gas in the side; Chinese Angelica blood replonishing is invigorated blood circulation, Radix Paeoniae Rubra, river waist; The Ramulus Cinnamomi warming YANG to expel cold, the Radix Clematidis expelling wind and dampness is for controlling the key medicine of arthromyodynia; Semen Coicis, Radix Saposhnikoviae invigorating spleen to remove dampness, Rhizoma Chuanxiong capable " gas in the blood, the blood in the lively atmosphere " is good at walking to make the final alterations pain, for drawing the priming sick institute that goes directly, the merit of the cold expelling of invigorating blood circulation is arranged with yellow wine.All medicines share to play altogether and fill blood, strengthening bone and muscle, and expelling wind and cold, dehumidifying is invigorated blood circulation, the effect of stimulating menstrual flow and reducing pain.
Medicine of the present invention has following advantage:
1. theory of Chinese medical science combines with practice.
2. curative effect is reliable, nontoxic pair of effect.Through the systematic observation to 60 these diseases of example, clinical effective rate reaches 90.8%.
3. convenient and practical.This prescription material source is abundant, draws materials conveniently, and dosage form is made does not need special installation.
Embodiment 1: be used for the prolapse of lumbar intervertebral disc patient, patient's waist company and right lower extremity pain, numb half a year, increased the weight of limitation of activity 1 month, the light red tongue white and thin fur, deep and tense pulse, there is tenderness on the L4/5 side, right lower extremity straight-leg raising test (+), large levies (+), and lumbar intervertebral disc CT shows that the L4/5 intercalated disc deviates from.Its drug regimen percentage ratio is as follows: Radix Astragali 18g, Radix Paeoniae Alba 15g, Ramulus Cinnamomi 15g, Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 18g, Radix Achyranthis Bidentatae 15g, Radix Clematidis 18g, Cortex Eucommiae 15g, Semen Coicis 15g, Radix Saposhnikoviae 15g, Radix Glycyrrhizae 9g.
Embodiment 2: be used for the lumbar intervertebral disc protrusion people, left limb pain half a year appears in patient repeatedly, and light during rest, heavy when movable, pale tongue with thin fur is white, stringy and rolling pulse.Left lower extremity straight-leg raising test (+) is strengthened test (+), and the lumbar X mating plate shows that the L4/5 intercalated disc is outstanding.Its medicament composing prescription percentage ratio is: Radix Astragali 18g, Radix Paeoniae Alba 15g, Ramulus Cinnamomi 15g, Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 18g, Radix Achyranthis Bidentatae 15g, Radix Clematidis 18g, Cortex Eucommiae 15g, Semen Coicis 15g, Radix Saposhnikoviae 15g, Radix Glycyrrhizae 9g.
Embodiment 3: be used for the lumbar intervertebral disc protrusion people.Patient's lumbago 15 days, emit to the right lower extremity shank outside during pain outbreak, limitation of activity, light red tongue purple, white and thin fur, stringy and rolling pulse, right lower extremity straight-leg raising test (+), strengthen test (+), its medicament composing prescription is as follows: Radix Astragali 18g, Radix Paeoniae Alba 15g, Ramulus Cinnamomi 15g, Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 18g, Radix Achyranthis Bidentatae 15g, Radix Clematidis 18g, Cortex Eucommiae 15g, Semen Coicis 15g, Radix Saposhnikoviae 15g, Radix Glycyrrhizae 9g.

Claims (2)

1. special side who treats prolapse of lumbar intervertebral disc comprises that distinctive clinical dialectical executing control, and is characterised in that percentage by weight is formed and formed to special side's medicine.
2. the Chinese medicine composition of deviating from according to the described treatment lumbar intervertebral disc of claim is characterized in that compositions processing mode, dosage form and consumption.
CN 01117635 2001-04-30 2001-04-30 Chinese medicine composition for treating sequelae for cerebral infraction Pending CN1383847A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01117635 CN1383847A (en) 2001-04-30 2001-04-30 Chinese medicine composition for treating sequelae for cerebral infraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01117635 CN1383847A (en) 2001-04-30 2001-04-30 Chinese medicine composition for treating sequelae for cerebral infraction

Publications (1)

Publication Number Publication Date
CN1383847A true CN1383847A (en) 2002-12-11

Family

ID=4662812

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01117635 Pending CN1383847A (en) 2001-04-30 2001-04-30 Chinese medicine composition for treating sequelae for cerebral infraction

Country Status (1)

Country Link
CN (1) CN1383847A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114869956A (en) * 2022-02-11 2022-08-09 福建中医药大学附属人民医院(福建省人民医院) Pharmaceutical composition for treating post-stroke motor dysfunction and preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114869956A (en) * 2022-02-11 2022-08-09 福建中医药大学附属人民医院(福建省人民医院) Pharmaceutical composition for treating post-stroke motor dysfunction and preparation method and application thereof
CN114869956B (en) * 2022-02-11 2023-09-22 福建中医药大学附属人民医院(福建省人民医院) Pharmaceutical composition for treating post-stroke dyskinesia, and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN100548350C (en) A kind of Chinese medicine for the treatment of thromboangiitis obliterans
CN102872442B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN101167817B (en) Traditional Chinese medicine for treating migraine
CN100376229C (en) A medicinal wine for treating rheumatic and rheumatoid disease
CN103784570A (en) Chinese herbal preparation for treating neonatal jaundice
CN101905006B (en) External medicament for treating traumatic injury
CN1257715A (en) Tincture for treating rheumatoid arthritis and its preparing process
CN104547666A (en) Traditional Chinese medicine composition for treating herpes zoster
CN106139110A (en) A kind of Chinese medicine composition for treating varicose veins of the lower extremity
CN106039245A (en) External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof
CN103393862A (en) Chinese medicinal composition for treating lumbocrural pain
CN108785578A (en) A kind of topical agent for treating pelvic inflammatory disease
CN102846903A (en) Traditional Chinese medicinal preparation for treating chronic pyelonephritis
CN101721651B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN105749207A (en) Traditional Chinese medicine composition for expelling wind and removing cold
CN100411648C (en) Medicine for treating atrophic arthritis
CN103830672A (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN101129425B (en) Traditional Chinese medicine for treating zoster
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN1383847A (en) Chinese medicine composition for treating sequelae for cerebral infraction
CN101596297B (en) Tinea-curing pill
CN101085303A (en) Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN1160102C (en) Chinese medicine for curing female chronic inflammation
CN1132096A (en) Chinese drug for treatment of hemiplegia
CN100411645C (en) Hyperosteogeny treating medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication